Deals Rumor Mill: Teva, Berkshire Hathaway, MBK Partners
Israel-based Teva Pharmaceuticals Industries Ltd. plans to raise as much as $25 billion to help finance its roughly $40.5 billion acquisition of Allergan PLC's generics business, Reuters reported on Thursday. According...To view the full article, register now.
Already a subscriber? Click here to view full article